# McGrath named inaugural research fellow of Institute of Cannabis Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/veterinary-cannabis-research-mcgrath-inaugural-research-fellow/ > **Published:** 2026-04-09T12:09:52-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T14:01:58-04:00 > **Clinical Summary:** Dr. McGrath's veterinary cannabis research advances CBD use for canine epilepsy as inaugural fellow at the Institute of Cannabis Research. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic EpilepsyCbdVeterinary MedicineResearchNeurology Why This Matters Dr. Stephanie McGrath’s appointment as the inaugural research fellow represents a significant milestone in legitimizing veterinary [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) within academic institutions. Her pioneering work on cannabinoids for canine epilepsy has established crucial precedent for evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) across species. Clinical Summary Dr. McGrath, a veterinary neurologist at Colorado State University, has been named the first research fellow of the Institute of [Cannabis Research](https://cedclinic.com/pediatric-cannabis-certification-care-children/). Her research has focused primarily on CBD efficacy for refractory epilepsy in dogs, including controlled trials that demonstrated seizure reduction with pharmaceutical-grade CBD. This appointment reflects growing institutional support for rigorous cannabis research in veterinary medicine, which often parallels and informs human applications. Dr. Caplan’s Take “McGrath’s work bridges a critical gap between preclinical models and human application — her canine epilepsy studies provide real-world evidence that often translates more directly to human medicine than rodent studies. This fellowship signals that serious academic institutions are finally investing in the infrastructure needed for quality cannabis research.” Clinical Perspective 🧠 Veterinary cannabis research like McGrath’s often provides valuable safety and efficacy data that informs human clinical practice, particularly for neurological conditions. Clinicians should watch for publications from this fellowship, as veterinary findings frequently precede human clinical applications and can offer insights into dosing, safety profiles, and therapeutic windows. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20McGrath%20named%20inaugural%20research%20fellow%20of%20Institute%20of%20Cannabis%20Research%20%40drcaplan&url=https%3A//cvmbs.source.colostate.edu/mcgrath-named-inaugural-research-fellow-of-institute-of-cannabis-research/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//cvmbs.source.colostate.edu/mcgrath-named-inaugural-research-fellow-of-institute-of-cannabis-research/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20McGrath%20named%20inaugural%20research%20fellow%20of%20Institute%20of%20Cannabis%20Research%20--%20via%20%40drcaplan.bsky.social%20https%3A//cvmbs.source.colostate.edu/mcgrath-named-inaugural-research-fellow-of-institute-of-cannabis-research/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://cvmbs.source.colostate.edu/mcgrath-named-inaugural-research-fellow-of-institute-of-cannabis-research/](https://cvmbs.source.colostate.edu/mcgrath-named-inaugural-research-fellow-of-institute-of-cannabis-research/) Table of Contents - [FAQ](#FAQ)[What is this clinical relevance rating about?](#What_is_this_clinical_relevance_rating_about) - [What medical conditions does this research focus on?](#What_medical_conditions_does_this_research_focus_on) - [Is this related to veterinary medicine as well?](#Is_this_related_to_veterinary_medicine_as_well) - [What type of cannabis compound is being studied?](#What_type_of_cannabis_compound_is_being_studied) - [Why is this considered clinically relevant?](#Why_is_this_considered_clinically_relevant) - [Related](#Related) ## FAQ #### What is this clinical relevance rating about? This is CED Clinical Relevance #70, rated as “Notable Clinical Interest.” It indicates emerging findings or policy developments in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) that are worth monitoring closely by healthcare professionals. #### What medical conditions does this research focus on? The primary focus appears to be on [epilepsy treatment](https://cedclinic.com/cannabidiol-for-epilepsy-treatment-rare-forms/) using CBD. The research encompasses both human and veterinary medicine applications of [cannabis-based therapies](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/). #### Is this related to veterinary medicine as well? Yes, this research includes veterinary medicine applications. The study appears to examine CBD treatments across both human and animal patients, particularly for seizure disorders. #### What type of cannabis compound is being studied? The research focuses specifically on CBD (cannabidiol). CBD is a non-psychoactive compound found in cannabis that has shown therapeutic potential for various medical conditions, particularly epilepsy. #### Why is this considered clinically relevant? This research represents emerging findings in cannabis medicine that could impact clinical practice. The “Notable Clinical Interest” rating suggests the findings may influence future treatment protocols or policy decisions regarding CBD use in [epilepsy management](https://cedclinic.com/cannabinoid-like-compound-seizure-reduction/). [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Flourish + Live Well's CBD Science Series CBD and Seizures in Dogs: What Science … – Instagram](https://cedclinic.com/a-new-hope-for-seizures-exploring-cbd-s-potential-for-dogs-with-epilepsy/) Explore scientific insights on CBD use for seizures in dogs, complementing veterinary cannabis research advancements. [Learn More](https://cedclinic.com/a-new-hope-for-seizures-exploring-cbd-s-potential-for-dogs-with-epilepsy/) [Q&A: What does science say about plants as medicine?](https://cedclinic.com/qa-what-does-science-say-about-plants-as-medicine/) Understand the scientific perspective on plant-based medicines including cannabis and their therapeutic potential. [Read Q&A](https://cedclinic.com/qa-what-does-science-say-about-plants-as-medicine/) Who is putting in the work for cannabis research? – YouTube Discover key contributors to cannabis research and their impact on advancing medical and veterinary cannabis knowledge. Watch Video ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).